Characterization of M2 antibodies in asymptomatic Chinese population

World Journal of Gastroenterology

Volumn 9, Issue 9, 2003, Pages 2128-2131

  Jiang, Xiao Hua ^a   Zhong, Ren Qing ^b   Fan, Xiao Yun ^c   Hu, Yin ^d   An, Feng ^e   Sun, Jian Wen ^a   Kong, Xian Tao ^b  

^a No 85 Hospital of PLA   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Center of Liver Research   (China)

^d SHANGHAI UNIVERSITY OF ENGINEERING SCIENCE   (China)

^e SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; MITOCHONDRION ANTIBODY; MITOCHONDRION M2 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; BIOCHEMISTRY; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GEOGRAPHIC PATHOLOGY; HISTOLOGY; HUMAN; IMMUNOLOGICAL PROCEDURES; JAUNDICE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRURITUS; QUANTITATIVE ANALYSIS;

EID: 0141606270     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i9.2128     Document Type: Article

References (37)

1. Medina J, Jones EA, Garcia Monzon C, Moreno Otero R. Immunopathogenesis of cholestatic autoimmune liver diseases. Eur J Clin Invest 2001; 31: 64-71
2. Heathcote EJ. Evidence-based therapy of primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1999; 11: 607-615
3. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF. Natural history of early primary biliary cirrhosis. Lancet 1996; 348: 1399-1402
4. Kisand KE, Metskula K, Kisand KV, Kivik T, Gershwin ME, Uibo R. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples. J Gastroenterol 2001; 36: 248-254
5. Koizumi H, Onozuka Y, Shibata M, Sano K, Ooshima Y, Morizane T, Ueno Y. Positive rate of anti-mitochondrial antibody in Japanese corporate workers. Rinsho Byori 2000; 48: 966-970
6. Turchany JM, Uibo R, Kivik T, Van De Water J, Prindiville T, Coppel RL, Gershwin ME. A study of antimitochondrial antibodies in a random population in Estonia. Am J Gastroenterol 1997; 92: 124-126
7. Nakano T, Inoue K, Hirohara J, Arita S, Higuchi K, Omata M, Toda G. Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC). Hepatol Res 2002; 22: 250-260
8. 2: The molecule versus the mimic. Hepatology 2001; 33: 792-801
9. 2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med 1995; 34: 496-501
10. Jones DE. Autoantigens in primary biliary cirrhosis. J Clin Pathol 2000; 53: 813-821
11. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, Fujikawa H, Gershwin ME. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243-248
12. 2 proteins in antimitochondrial antibody-negative patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1994; 9: 7-12
13. 2 in primary biliary cirrhosis. J Gastroenterol 2001; 36: 33-38
14. Miyakawa H, Kawaguchi N, Kikuchi K, Fujikawa H, Kitazawa E, Matsushita M. Definition of antigen specificity for antimitochondrial proteins detected by Western blotting using native mitochondrial proteins in primary biliary cirrhosis. Hepatol Res 2001; 21: 101-107
15. Jensen WA, Jois JA, Murphy P, De Giorgio J, Brown B, Rowley MJ, Mackay IR. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis. Clin Chem Lab Med 2000; 38: 753-758
16. Leung PS, Van De Water J, Coppel RL, Nakanuma Y, Munoz S, Gershwin ME. Molecular aspects and the pathological basis of primary biliary cirrhosis. J Autoimmun 1996; 9: 119-128
17. Strassburg CP, Manns MP. Autoimmune tests in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 585-599
18. Quaranta S, Shulman H, Ahmed A, Shoenfeld Y, Peter J, McDonald GB, Van De Water J, Coppel R, Ostlund C, Worman HJ, Rizzetto M, Tsuneyama K, Nakanuma Y, Ansari A, Locatelli F, Paganin S, Rosina F, Manns M, Gershwin ME. Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol 1999; 91: 106-116
19. 2 triple autoantigen and its application in Chinese patients with primary biliary cirrhosis. World J Gastroenterol 2003; 9: 1352-1355
20. 2 autoantibodies using a humanized triple autoantigen in diagnosis of primary billiary cirrhosis. Zhonghua Ganzangbing Zazhi 2002; 10: 341-343
21. James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999; 30: 390-394
22. Metcalf J, James O. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis 1997; 17: 13-22
23. Metcalf JV, Bhopal RS, Gray J, Howel D, James OF. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol 1997; 26: 830-836
24. Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000; 31: 1005-1013
25. Strassburg CP, Jaeckel E, Manns MP. Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1999; 11: 595-601
26. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Palmer JM, Heathcote EJ. Antimitochondrial antibody negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis. Gut 1994; 35: 260-265
27. Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 1995; 90: 247-249
28. Heathcote J. Autoimmune cholangitis. Gut 1997; 40: 440-442
29. Ikuno N, Sceal M, Davies JM, Whittingham SF, Omagari K, Mackay IR, Rowley MJ. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display. Hepatology 2001; 34: 478-486
30. Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, Yano M, Kohno S, Nakanuma Y, Penner E, Wesierska Gadek J, Reynoso Paz S, Gershwin ME, Anderson J, Jois JA, Mackay IR. Autoimmune cholangitis and primary biliary cirrhosis-an autoimmune enigma. Liver 1999; 19: 122-128
31. Invernizzi P, Crosignani A, Battezzati PM, Covini G, De Valle G, Larghi A, Zuin M, Podda M. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 1997; 25: 1090-1095
32. Kaserer K, Exner M, Mosberger I, Penner E, Wrba F. Characterization of the inflammatory infiltrate in autoimmune cholangitis. A morphological and immunohistochemical study. Virchows Arch 1998; 432: 217-222
33. Mayo MJ, Lipsky PE, Miller SN, Stastny P, Combes B. Similar T-cell oligoclonality in antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Dig Dis Sci 2001; 46: 345-351
34. Fujioka S, Yamamoto K, Okamoto R, Miyake M, Ujike K, Shimada N, Terada R, Miyake Y, Nakajima H, Piao CY, Iwasaki Y, Tanimizu M, Tsuji T. Laparoscopic features of primary biliary cirrhosis in AMA-positive and AMA-negative patients. Endoscopy 2002; 34: 318-321
35. 2 antibody by immunoblotting in autoimmune cholangitis: Is autoimmune cholangitis an early stage of primary biliary cirrhosis? J Gastroenterol 1999; 34: 607-612
36. Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of primary biliary cirrhosis. Semin Liver Dis 2002; 22: 291-302
37. Zhang F, Jia J, Wang B, Qian L, Yin S, Wang Y, Cui Y, You H, Ma H, Wang H, Zhang C. Clinical characteristics of primary biliary cirrhosis: A report of 45 cases. Zhonghua Neike Zazhi 2002; 41: 163-167